Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dividend --> Earnings--> M&A Announcement

Lamberts, I am a dividend supporter and continue to be one. I would also suggest that a reaffirmation of the stock repurchase program, regardless of M&A, be made by Turley and the Board. Never again should PTSC agree to an NDA situation in which it is (apparently) foreclosed from buying back its own stock for so long (if indeed that is the case).

Dividends and buybacks help keep the MM's and manipulators honest (or at least a shadow of it). JMHO and GLTAL.

Share
New Message
Please login to post a reply